Women Advised to Get Yearly Mammograms Starting at Age 40
By MedImaging International staff writers Posted on 08 Jan 2015 |
Image: bilateral mediolateral oblique (MLO) views from screening mammography (Photo courtesy of RSNA).
Image: A spot magnification view demonstrates an irregular spiculated mass with associated calcifications in the upper outer left breast (Photo courtesy of RSNA).
Image: Screening mammogram demonstrating calcifications in the upper outer left breast. Bilateral cranio-caudal views shown (Photo courtesy of RSNA).
A study of breast tumors identified with screening mammography revealed that a strong family history and dense breast tissue were typically absent in women between the ages of 40 and 49 diagnosed with breast cancer.
The study’s findings were presented at the annual meeting of the Radiological Society of North America (RSNA), held November 30 to December 4, 2014, in Chicago (IL, USA). “Screening recommendations for this age group continue to be debated,” said Bonnie N. Joe, MD, PhD, associate professor in residence and chief of women’s imaging at the University of California, San Francisco (UCSF; USA). “Recent publications have suggested risk-based screening based on family history and breast density. However, our study shows that this approach would miss a significant percentage of invasive cancers and could potentially be dangerous.”
The retrospective study, conducted at UCSF, included 136 women between the ages of 40 and 49 with breast cancer identified by screening mammography between 1997 and 2012. Symptomatic patients undergoing diagnostic mammography and those with a personal history of breast cancer were excluded from the study. Patient family history, breast density, type of malignancy, lymph node status, and tumor receptor status were logged. “Notably, we found that almost 90% of the invasive cancers we would have missed using risk-based triage had positive receptor status, meaning they were very treatable and worth finding early,” Dr. Joe said.
Of the 136 breast cancer cases identified, 50% were diagnosed as invasive, and 50% were diagnosed as ductal carcinoma in situ (DCIS), an early noninvasive form of breast cancer, although 88% of DCIS cases were intermediate or high grade. A very strong family history was absent in 90% of patients, and extremely dense breast tissue was absent in 86%. Seventy-eight percent of patients had neither a strong family history nor extremely dense breasts, including 79% of the cases of invasive disease.
“Our results show that by exclusively using a risk-based approach to screening mammography, we could potentially miss more than 75% of breast cancers in women in their 40s, thereby eliminating most of the survival benefit from screening mammography that has been previously shown in randomized controlled trials,” Dr. Joe commented.
Dr. Joe advises advocates of risk-based screening to continue research to find more effective ways of risk-based triage. “Neither family history nor breast density in combination or alone are sufficient risk factors to safely triage patients in risk-based screening,” she explained.
Regular annual screening mammography has traditionally been recommended by organizations such as the American Cancer Society (ACS) and the American Medical Association (AMA) for all women beginning at age 40. In 2009, the United States Preventive Services Task Force (USPSTF) issued controversial new guidelines recommending screening with mammography every two years beginning at age 50. “Based on our current knowledge and evidence shown in previous trials, it is still safest to get annual mammograms starting at age 40 in order to maximize the survival benefit of screening mammography,” Dr. Joe concluded.
Related Links:
University of California, San Francisco
The study’s findings were presented at the annual meeting of the Radiological Society of North America (RSNA), held November 30 to December 4, 2014, in Chicago (IL, USA). “Screening recommendations for this age group continue to be debated,” said Bonnie N. Joe, MD, PhD, associate professor in residence and chief of women’s imaging at the University of California, San Francisco (UCSF; USA). “Recent publications have suggested risk-based screening based on family history and breast density. However, our study shows that this approach would miss a significant percentage of invasive cancers and could potentially be dangerous.”
The retrospective study, conducted at UCSF, included 136 women between the ages of 40 and 49 with breast cancer identified by screening mammography between 1997 and 2012. Symptomatic patients undergoing diagnostic mammography and those with a personal history of breast cancer were excluded from the study. Patient family history, breast density, type of malignancy, lymph node status, and tumor receptor status were logged. “Notably, we found that almost 90% of the invasive cancers we would have missed using risk-based triage had positive receptor status, meaning they were very treatable and worth finding early,” Dr. Joe said.
Of the 136 breast cancer cases identified, 50% were diagnosed as invasive, and 50% were diagnosed as ductal carcinoma in situ (DCIS), an early noninvasive form of breast cancer, although 88% of DCIS cases were intermediate or high grade. A very strong family history was absent in 90% of patients, and extremely dense breast tissue was absent in 86%. Seventy-eight percent of patients had neither a strong family history nor extremely dense breasts, including 79% of the cases of invasive disease.
“Our results show that by exclusively using a risk-based approach to screening mammography, we could potentially miss more than 75% of breast cancers in women in their 40s, thereby eliminating most of the survival benefit from screening mammography that has been previously shown in randomized controlled trials,” Dr. Joe commented.
Dr. Joe advises advocates of risk-based screening to continue research to find more effective ways of risk-based triage. “Neither family history nor breast density in combination or alone are sufficient risk factors to safely triage patients in risk-based screening,” she explained.
Regular annual screening mammography has traditionally been recommended by organizations such as the American Cancer Society (ACS) and the American Medical Association (AMA) for all women beginning at age 40. In 2009, the United States Preventive Services Task Force (USPSTF) issued controversial new guidelines recommending screening with mammography every two years beginning at age 50. “Based on our current knowledge and evidence shown in previous trials, it is still safest to get annual mammograms starting at age 40 in order to maximize the survival benefit of screening mammography,” Dr. Joe concluded.
Related Links:
University of California, San Francisco
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection